These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 7652143)
1. Secondary mania associated with the use of felbamate. Hill RR; Stagno SJ; Tesar GE Psychosomatics; 1995; 36(4):404-6. PubMed ID: 7652143 [No Abstract] [Full Text] [Related]
2. Felbamate. Sofia RD; Kramer L; Perhach JL; Rosenberg A Epilepsy Res Suppl; 1991; 3():103-8. PubMed ID: 1777064 [No Abstract] [Full Text] [Related]
3. New antiepileptic medications. Lee EK West J Med; 1995 Nov; 163(5):475-6. PubMed ID: 8533417 [No Abstract] [Full Text] [Related]
5. Felbamate: successful development of a new compound for the treatment of epilepsy. Schmidt D Epilepsia; 1993; 34 Suppl 7():S30-3. PubMed ID: 8243376 [TBL] [Abstract][Full Text] [Related]
6. Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsy. Sachdeo R; Narang-Sachdeo SK; Shumaker RC; Perhach JL; Lyness WH; Rosenberg A Epilepsia; 1997 Aug; 38(8):887-92. PubMed ID: 9579889 [TBL] [Abstract][Full Text] [Related]
8. Alternative analyses for antiepileptic drug trials. Pledger GW; Sahlroot JT Epilepsy Res Suppl; 1993; 10():167-74. PubMed ID: 8251092 [No Abstract] [Full Text] [Related]
10. Rectal administration of felbamate in a child with Lennox-Gastaut syndrome. Grossmann R; Maytal J; Fernando J Neurology; 1994 Oct; 44(10):1979. PubMed ID: 7936261 [No Abstract] [Full Text] [Related]
11. [Felbamate: a long-term study in subjects with refractory epilepsy]. De Romanis F; Sopranzi N Clin Ter; 1997 Mar; 148(3):83-7. PubMed ID: 9377844 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of felbamate in children under 4 years of age: a retrospective chart review. Grosso S; Cordelli DM; Coppola G; Franzoni E; Verrotti A; Berardi R; Balestri P Eur J Neurol; 2008 Sep; 15(9):940-6. PubMed ID: 18637038 [TBL] [Abstract][Full Text] [Related]
14. Thrombocytopenia in association with adjunctive felbamate use. Ney GC; Schaul N; Loughlin J; Rai K; Chandra V Neurology; 1994 May; 44(5):980-1. PubMed ID: 8190314 [No Abstract] [Full Text] [Related]
15. Criteria for use of felbamate in adult, adolescent, and child inpatients and outpatients. Luer MS Am J Hosp Pharm; 1994 Jul; 51(13):1701-3; Quiz 1704-5. PubMed ID: 7942896 [No Abstract] [Full Text] [Related]
16. Drug concentrations in human brain tissue samples from epileptic patients treated with felbamate. Adusumalli VE; Wichmann JK; Kucharczyk N; Kamin M; Sofia RD; French J; Sperling M; Bourgeois B; Devinsky O; Dreifuss FE Drug Metab Dispos; 1994; 22(1):168-70. PubMed ID: 8149879 [No Abstract] [Full Text] [Related]
17. [The pharmacologic and clinical profile of the new anticonvulsant felbamate--an overview]. Steinhoff BJ Fortschr Neurol Psychiatr; 1994 Oct; 62(10):379-88. PubMed ID: 8001894 [TBL] [Abstract][Full Text] [Related]
19. The long-term use of felbamate in children with severe refractory epilepsy. Cilio MR; Kartashov AI; Vigevano F Epilepsy Res; 2001 Nov; 47(1-2):1-7. PubMed ID: 11673015 [TBL] [Abstract][Full Text] [Related]
20. The use of felbamate in patients with periodic lateralized epileptiform discharges (PLEDs). Hughes JR; Fuller T Clin Electroencephalogr; 1995 Jul; 26(3):180-3. PubMed ID: 7554306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]